Biotech Acquisition Company Announces Public Filing of Registration Statement on Form S-4 Related to Proposed Merger with Blade Therapeutics, Inc.
NEW YORK, March 16, 2022 /PRNewswire/ -- Biotech Acquisition Organization (NASDAQ: BIOT) ("BAC"), a publicly traded distinctive goal acquisition enterprise...
